These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36241556)

  • 1. CPSF6-RARG-positive acute myeloid leukaemia resembles acute promyelocytic leukaemia but is insensitive to retinoic acid and arsenic trioxide.
    Li J; Yan WZ; Bai LH; Jiang YF; Peng HL; Shen JK; Li RJ
    Pathology; 2023 Apr; 55(3):407-412. PubMed ID: 36241556
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.
    Chen X; Wang F; Zhang Y; Teng W; Cao P; Ma X; Liu M; Tian Y; Wang T; Nie D; Zhang J; Liu H; Wang W
    Br J Cancer; 2019 May; 120(11):1023-1025. PubMed ID: 30996344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.
    Kulkarni UP; Selvarajan S; Lionel S; Prakash MA; Palani HK; Balasundaram N; Venkataraman A; Korula A; Devasia AJ; Fouzia NA; Janet NB; Nair SC; Abraham A; Mani T; Lakshmanan J; Arunachalam AK; Balasubramanian P; George B; Mathews V
    Blood Cancer J; 2022 Jan; 12(1):22. PubMed ID: 35102152
    [No Abstract]   [Full Text] [Related]  

  • 4. A short report of novel
    Song Y; Hou J; Wan L; Liu K; Zhou C; Wei S; Zhang G; Lin D; Li Y; Fang Q; Liu Y; Gong B; Gong X; Wang Y; Wei H; Wang J; Mi Y
    Hematology; 2022 Dec; 27(1):518-522. PubMed ID: 35544458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all-trans retinoic acid and arsenic trioxide sensitivity.
    Ng Liet Hing M; Ryland GL; Nguyen T; Tiong IS; Dun K; Ninkovic S; Nedumannil R; Westerman DA; Blombery PA; Chan KL; Bajel A
    Br J Haematol; 2023 Aug; 202(4):893-896. PubMed ID: 37280781
    [No Abstract]   [Full Text] [Related]  

  • 6. First report of successful management of acute promyelocytic leukemia in a pregnant female with All-Trans-Retinoic Acid and Arsenic Trioxide-based induction regimen.
    Khosla H; Jain A; Tatawadiya S; Prasad P; Nagpal K; Chaudhry S; Sharma M; Gupta DK; Saluja S; Jain A
    Blood Cells Mol Dis; 2020 Nov; 85():102476. PubMed ID: 32688220
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
    Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute Promyelocytic Leukemia: New treatment strategies with ATRA and ATO - AML-BFM-Recommendations].
    Creutzig U; Dworzak M; von Neuhoff N; Rasche M; Reinhardt D
    Klin Padiatr; 2018 Oct; 230(6):299-304. PubMed ID: 30399642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
    Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute promyelocytic leukaemia].
    Tøstesen M; Østergård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
    Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment of acute promyelocytic leukaemia without chemotherapy and blood transfusion].
    Tøstesen M; Østgård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
    Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide and all-trans retinoic acid in the treatment of children with newly diagnosed acute promyelocytic leukemia.
    Li SY; Lu Y; Liu HC; Gang EJ; Le J; Qian SY; Tang SH; Si T; Pei RZ
    Leuk Lymphoma; 2021 May; 62(5):1267-1270. PubMed ID: 33439058
    [No Abstract]   [Full Text] [Related]  

  • 13. PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.
    Tang FF; Lu SY; Zhao XS; Qin YZ; Liu XH; Jia JS; Wang J; Gong LZ; Jiang Q; Zhao T; Shi HX; Chang YJ; Huang XJ; Jiang H
    Br J Haematol; 2021 Dec; 195(5):722-730. PubMed ID: 34405393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher than normal mitochondrial DNA content associated with better outcome in acute promyelocytic leukaemia? Maybe.
    Wiernik PH
    Br J Haematol; 2023 Jan; 200(2):126-127. PubMed ID: 36342482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid.
    Singh C; Saini M; Jain A; Lad D; Prakash G; Khadwal A; Naseem S; Malhotra P
    Blood Cancer J; 2024 Jan; 14(1):14. PubMed ID: 38238308
    [No Abstract]   [Full Text] [Related]  

  • 16. Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.
    Strocchio L; Gurnari C; Santoro N; Putti MC; Micalizzi C; Zecca M; Cuccurullo R; Girardi K; Diverio D; Testi AM; Lo-Coco F; Locatelli F
    Br J Haematol; 2019 Apr; 185(2):360-363. PubMed ID: 30028005
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.
    Breccia M; Foà R
    Expert Rev Hematol; 2019 Feb; 12(2):81-87. PubMed ID: 30572725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
    Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
    Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia.
    Imagawa J
    Leuk Lymphoma; 2018 Dec; 59(12):3013-3015. PubMed ID: 29616847
    [No Abstract]   [Full Text] [Related]  

  • 20. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial.
    Russell N; Burnett A; Hills R; Betteridge S; Dennis M; Jovanovic J; Dillon R; Grimwade D;
    Blood; 2018 Sep; 132(13):1452-1454. PubMed ID: 30097508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.